Editorial Expression of Concern: A melanocyte lineage program confers resistance to MAP kinase pathway inhibition

Johannessen, Cory M.; Johnson, Laura A.; Piccioni, Federica; Townes, Aisha; Frederick, Dennie T.; Donahue, Melanie K.; Narayan, Rajiv; Flaherty, Keith T.; Wargo, Jennifer A.; Root, David E.; Garraway, Levi A.

doi:10.1038/s41586-025-09027-6

Editorial Expression of Concern
Published: 24 April 2025

Editorial Expression of Concern: A melanocyte lineage program confers resistance to MAP kinase pathway inhibition

Cory M. Johannessen^1,2,3,
Laura A. Johnson^1,2^nAff5,
Federica Piccioni¹,
Aisha Townes¹,
Dennie T. Frederick⁴,
Melanie K. Donahue¹,
Rajiv Narayan¹,
Keith T. Flaherty⁴,
Jennifer A. Wargo⁴,
David E. Root¹ &
…
Levi A. Garraway^1,2,3

Nature volume 641, page E7 (2025)Cite this article

12k Accesses
9 Altmetric
Metrics details

Addendum to: Nature https://doi.org/10.1038/nature12688 Published online 3 November 2013

Nature is publishing an Editorial Expression of Concern on the article “A melanocyte lineage program confers resistance to MAP kinase pathway inhibition”, by Johannessen et al.

Author information

Laura A. Johnson
Present address: Graduate Program in Cell and Molecular Physiology, Sackler School of Graduate Biomedical Sciences, School of Medicine, Tufts University, Boston, Massachusetts, USA

Authors and Affiliations

The Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
Cory M. Johannessen, Laura A. Johnson, Federica Piccioni, Aisha Townes, Melanie K. Donahue, Rajiv Narayan, David E. Root & Levi A. Garraway
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Cory M. Johannessen, Laura A. Johnson & Levi A. Garraway
Harvard Medical School, Boston, Massachusetts, USA
Cory M. Johannessen & Levi A. Garraway
Department of Surgical Oncology, Medical Oncology and Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA
Dennie T. Frederick, Keith T. Flaherty & Jennifer A. Wargo

Authors

Cory M. Johannessen
View author publications
Search author on:PubMed Google Scholar
Laura A. Johnson
View author publications
Search author on:PubMed Google Scholar
Federica Piccioni
View author publications
Search author on:PubMed Google Scholar
Aisha Townes
View author publications
Search author on:PubMed Google Scholar
Dennie T. Frederick
View author publications
Search author on:PubMed Google Scholar
Melanie K. Donahue
View author publications
Search author on:PubMed Google Scholar
Rajiv Narayan
View author publications
Search author on:PubMed Google Scholar
Keith T. Flaherty
View author publications
Search author on:PubMed Google Scholar
Jennifer A. Wargo
View author publications
Search author on:PubMed Google Scholar
David E. Root
View author publications
Search author on:PubMed Google Scholar
Levi A. Garraway
View author publications
Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Levi A. Garraway.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Johannessen, C.M., Johnson, L.A., Piccioni, F. et al. Editorial Expression of Concern: A melanocyte lineage program confers resistance to MAP kinase pathway inhibition. Nature 641, E7 (2025). https://doi.org/10.1038/s41586-025-09027-6

Download citation

Published: 24 April 2025
Issue date: 08 May 2025
DOI: https://doi.org/10.1038/s41586-025-09027-6

Editorial Expression of Concern: A melanocyte lineage program confers resistance to MAP kinase pathway inhibition

Enjoying our latest content?
Log in or create an account to continue

Author information

Authors and Affiliations

Corresponding author

Rights and permissions

About this article

Cite this article

A melanocyte lineage program confers resistance to MAP kinase pathway inhibition

Search

Quick links

Enjoying our latest content? Log in or create an account to continue

Author information

Authors and Affiliations

Corresponding author

Rights and permissions

About this article

Cite this article

Share this article

Search

Quick links

Enjoying our latest content?
Log in or create an account to continue